Thomas Shrader
Stock Analyst at BTIG
(0.95)
# 3,636
Out of 4,873 analysts
47
Total ratings
34.15%
Success rate
-11.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALDX Aldeyra Therapeutics | Maintains: Buy | $11 → $9 | $3.51 | +156.41% | 1 | Apr 7, 2025 | |
| OVID Ovid Therapeutics | Maintains: Buy | $5 → $4 | $0.31 | +1,171.86% | 3 | Mar 24, 2025 | |
| PCVX Vaxcyte | Reiterates: Buy | $160 | $33.09 | +383.53% | 4 | Feb 24, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Buy | $41 | $13.98 | +193.38% | 1 | Jan 28, 2025 | |
| ALEC Alector | Maintains: Buy | $16 → $5 | $1.49 | +236.70% | 2 | Nov 26, 2024 | |
| ATHA Athira Pharma | Downgrades: Neutral | n/a | $0.31 | - | 3 | Sep 4, 2024 | |
| ACIU AC Immune | Initiates: Buy | $8 | $2.05 | +290.24% | 1 | May 31, 2024 | |
| PMN ProMIS Neurosciences | Initiates: Buy | $8 | $0.49 | +1,549.48% | 1 | Oct 3, 2023 | |
| DTIL Precision BioSciences | Maintains: Buy | $180 → $60 | $4.24 | +1,315.09% | 1 | Jul 28, 2023 | |
| BHVN Biohaven | Reiterates: Buy | $24 | $14.33 | +67.48% | 2 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $7 | $2.39 | +192.89% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.91 | +153.81% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $13 | $0.41 | +3,101.18% | 3 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $31 | $95.11 | -67.41% | 3 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $1.95 | +412.82% | 2 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $1.23 | +1,688.62% | 2 | Oct 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $14 | $7.37 | +89.96% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $1.38 | +3,595.65% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.88 | +751.06% | 1 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.94 | - | 1 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.45 | - | 2 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $58 | $9.76 | +494.26% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.52 | +97.37% | 3 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $397 → $346 | $127.31 | +171.78% | 3 | Feb 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.37 | - | 1 | Jun 30, 2017 |
Aldeyra Therapeutics
Apr 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $3.51
Upside: +156.41%
Ovid Therapeutics
Mar 24, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.31
Upside: +1,171.86%
Vaxcyte
Feb 24, 2025
Reiterates: Buy
Price Target: $160
Current: $33.09
Upside: +383.53%
Arcturus Therapeutics Holdings
Jan 28, 2025
Initiates: Buy
Price Target: $41
Current: $13.98
Upside: +193.38%
Alector
Nov 26, 2024
Maintains: Buy
Price Target: $16 → $5
Current: $1.49
Upside: +236.70%
Athira Pharma
Sep 4, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.31
Upside: -
AC Immune
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $2.05
Upside: +290.24%
ProMIS Neurosciences
Oct 3, 2023
Initiates: Buy
Price Target: $8
Current: $0.49
Upside: +1,549.48%
Precision BioSciences
Jul 28, 2023
Maintains: Buy
Price Target: $180 → $60
Current: $4.24
Upside: +1,315.09%
Biohaven
Jun 6, 2023
Reiterates: Buy
Price Target: $24
Current: $14.33
Upside: +67.48%
May 25, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $2.39
Upside: +192.89%
May 18, 2023
Initiates: Buy
Price Target: $15
Current: $5.91
Upside: +153.81%
Mar 28, 2023
Maintains: Buy
Price Target: $68 → $13
Current: $0.41
Upside: +3,101.18%
Mar 20, 2023
Maintains: Buy
Price Target: $26 → $31
Current: $95.11
Upside: -67.41%
Nov 14, 2022
Maintains: Buy
Price Target: $30 → $10
Current: $1.95
Upside: +412.82%
Oct 5, 2022
Maintains: Buy
Price Target: $15 → $22
Current: $1.23
Upside: +1,688.62%
May 24, 2022
Maintains: Buy
Price Target: $31 → $14
Current: $7.37
Upside: +89.96%
Apr 20, 2021
Initiates: Buy
Price Target: $51
Current: $1.38
Upside: +3,595.65%
Mar 8, 2021
Initiates: Buy
Price Target: $16
Current: $1.88
Upside: +751.06%
Feb 3, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.94
Upside: -
Oct 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $14.45
Upside: -
Sep 15, 2020
Maintains: Buy
Price Target: $51 → $58
Current: $9.76
Upside: +494.26%
Apr 3, 2020
Maintains: Buy
Price Target: $4 → $3
Current: $1.52
Upside: +97.37%
Feb 21, 2019
Downgrades: Hold
Price Target: $397 → $346
Current: $127.31
Upside: +171.78%
Jun 30, 2017
Downgrades: Hold
Price Target: n/a
Current: $0.37
Upside: -